Drug Treatment

ADDICTION TREATMENT AND PREVENTION

Gender, Class, and Treatment
Radcliffe, P. (2011). Motherhood, pregnancy, and the negotiation of identity: The moral career of drug treatment. Social science & medicine, 72(6), 984-991.
Radcliffe, P. (2011). Substance-misusing women: Stigma in the maternity setting.
British journal of midwifery, 19(8), 497-506.
Drug Policy
Stevens, A. (2010). Drugs, crime and public health: The political economy of drug policy. Routledge.
Mena, F., & Hobbs, D. (2010). Narcophobia: drugs prohibition and the generation of human rights abuses.
Trends in Organized Crime, 13(1), 60-74.
Pryce, S. (2012).
Fixing drugs: the politics of drug prohibition. Palgrave Macmillan.

Alcoholics Anonymous and Alcohol Treatment

Humphreys, K. (2000). Community narratives and personal stories in Alcoholics Anonymous. Journal of community psychology, 28(5), 495-506.
Kitchin, H. A. (2002). Alcoholics Anonymous discourse and members' resistance in a virtual community: exploring tensions between theory and practice.
Contemp. Drug Probs., 29, 749.
Ratliff, J. (2003). Community identity in an Alcoholics Anonymous group: Discourse contention and integration.
Alcoholism Treatment Quarterly, 21(3), 41-57.
Swora, M. G. (2001). Personhood and disease in Alcoholics Anonymous: A perspective from the anthropology of religious healing.
Mental Health, Religion & Culture, 4(1), 1-21.
Swora, M. G. (2002). Narrating community: The creation of social structure in Alcoholics Anonymous through the performance of autobiography.
Narrative Inquiry, 11(2), 363-384.
Hoffmann, H. C. (2006). Criticism as deviance and social control in Alcoholics Anonymous.
Journal of contemporary ethnography, 35(6), 669-695.
Schmidt, L., Greenfield, T., & Mulia, N. (2006). Unequal treatment: racial and ethnic disparities in alcoholism treatment services.
Alcohol Research and Health, 29(1), 49.

The Brain Disease Paradigm
Hammer, R., Dingel, M., Ostergren, J., Partridge, B., McCormick, J., & Koenig, B. A. (2013). Addiction: Current criticism of the brain disease paradigm. AJOB neuroscience, 4(3), 27-32.